add chat code
Mereo Bioph Company Financial Information
Mereo Bioph

Mereo Bioph (MPH)

Company name:Mereo Bioph
EPIC:MPHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BZ4G2K23
Market Segment:ASQ1Share Type:DE
WWW Address:http://mereobiopharma.com/investors/Description:ORD GBP0.003
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 180.00 uk.advfn.com/p.php?gfx=/gb/dot 0.0 [0.00] 170.00 190.00 180.00 180.00 180.00 1,538
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 128.08 71.16 0.42 -56.00 - - - 353.00 - 180.00

Mereo Bioph Key Figures

(at previous day's close)
Market Cap.128.08m
Shares In Issue71.16m
Prev. Close180.00
PE Ratio- 
Dividend Yield-%
EPS - basic-56.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-45.18p
Return On Equity (ROE)-62.09%
Operating Margin-%
PEG Factor- 
EPS Growth Rate11.11%
Dividends PS Growth Rate-%
Net Debt-16.19m
Gross Gearing35.14%
Quick Assets60.68m
Net Working Capital51.06m
Intangibles / Fixed Assets92.56%
Turnover PS-p
Pre-Tax Profit PS-65.98p
Retained Profit PS-54.53p
Cash PS70.33p
Net Cash PS56.82p
Net Tangible Asset Value PS *41.43p
Net Asset Value PS87.81p
Spread20.00 (10.53%) 

Mereo Bioph Balance Sheet

LSE:MPH:Liabilities+EQLSE:MPH:Assets

Share Price Performance

Sample Period HighLow
1 week227.00180.00
4 weeks245.00180.00
12 weeks316.00180.00
1 year353.00180.00

Share Price Chart (5 years)

Mereo Bioph Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week226.00-46.00-20.35180.000.00180.00
4 weeks245.00-65.00-26.53180.000.00212.40
12 weeks315.00-135.00-42.86180.000.03270.08
26 weeks337.00-157.00-46.59180.000.03303.57
1 year312.50-132.50-42.40180.000.04312.61
3 years237.50-57.50-24.21180.000.02310.16
5 years237.50-57.50-24.21180.000.02310.16

Mereo Bioph Key Management Ratios

Mereo Bioph Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.40 
Tobin's Q Ratio (excl. intangibles)2.06 
Dividend Yield-%
Market-to-Book Ratio2.05 
Price-to-Pre-Tax Profit PS-2.73 
Price-to-Retained Profit PS-3.30 
Price-to-Cash Flow PS-3.98 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS4.34 
Price-to-Cash PS2.56 
Net Working Capital PS71.76 
Price Pct to Working Capital PS2.51%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Mereo Bioph Financial Ratios

(Leverage Ratios)
Debt Ratio27.95%
Debt-to-Equity Ratio0.39 
Debt-to-Equity Ratio (excl. Intgbl)0.82 
Debt-to-Equity Market Value0.19 
Net Gearing-16.81%
Net Gearing (excl. Intangibles)-25.57%
Gross Gearing35.14%
Gross Gearing (excl. Intangibles)53.45%
Gearing Under 1 Year9.98%
Gearing Under 1 Year (excl. Intgbl)15.19%
Assets/Equity1.54 
Cash/Equity80.09 
(Liquidity Ratios)
Net Working Capital to Total Assets53.00%
Current Ratio6.31 
Quick Ratio (Acid Test)6.31 
Liquidity Ratio5.20 
Cash & Equiv/Current Assets82.48%
(Solvency Ratios)
Enterprise Value102.27m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.33 
CFO/Debt-0.95 
Total Debt/Equity Market Value0.26 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.72 
Total Debt33.85m
Total Debt/Net Current Assets0.66%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
0.42060.2963

Mereo Bioph Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-54.14%
Return On Assets (ROA)-42.38%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-62.09%
Return On Investment (ROI)-45.57%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Mereo Bioph Dividends

Sorry No Data Available

Mereo Bioph Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)
turnover----m
pre tax profit-33.72--46.95-m
attributable profit-28.39--38.80-m
retained profit-28.39--38.80-m
eps - basic (p)-63.00 -56.00 
eps - diluted (p)-63.00 -56.00 
dividends per share- - 

Mereo Bioph Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)
LSE:MPH:Liabilities+EQLSE:MPH:AssetsLSE:MPH:Liabilities+EQLSE:MPH:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)
ASSETS
fixed assets fixed assets0.170.20%0.150.16%m
intangibles intangibles25.8129.75%33.0134.26%m
fixed investments fixed investments--%2.502.60%m
current assets - other current assets - other--%--%m
stocks stocks--%--%m
debtors debtors7.208.30%10.6311.04%m
cash & securities cash & securities53.5861.75%50.0451.95%m
TOTAL86.76100%96.34100%m
LIABILITIES
creditors - short creditors - short3.213.70%9.629.98%m
creditors - long creditors - long4.304.95%24.2325.16%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL7.518.65%33.8535.14%m
EQUITY
ord cap, reserves ord cap, reserves79.2691.35%62.4864.86%m
prefs, minorities prefs, minorities--%--%m
TOTAL79.2691.35%62.4864.86%m
OTHER
NAV Basic- - 
NAV Diluted- - 

Mereo Bioph Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)
Operating CF-27.40-32.15m
Pre-Financing CF-27.03-35.89m
Retained CF41.33-2.15m

Mereo Bioph Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MMF)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20181022 11:51:31